QuidelOrtho Corp SEC filings QDEL

QuidelOrtho Corp has 502 filings in SEC EDGAR's recent list, going back to Jan 31, 2022. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 28, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, officer or director change). The company's fiscal year ends on January 1.

Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 27, 2026
10-Q Quarterly report Aug 7, 2026 Jun 28, 2026
10-Q Quarterly report May 6, 2026 Mar 29, 2026
10-Q Quarterly report Nov 6, 2025 Sep 28, 2025
10-Q Quarterly report Aug 6, 2025 Jun 29, 2025
10-Q Quarterly report May 8, 2025 Mar 30, 2025
10-Q Quarterly report Nov 8, 2024 Sep 29, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
10-Q Quarterly report Nov 2, 2023 Oct 1, 2023
10-Q Quarterly report Aug 9, 2023 Jul 2, 2023
10-Q Quarterly report May 4, 2023 Apr 2, 2023
10-Q Quarterly report Nov 4, 2022 Oct 2, 2022
10-Q Quarterly report Aug 5, 2022 Jul 3, 2022

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
QDEL (Nasdaq)
Fiscal year ends
January 1
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1906324
Former names
Coronado Topco, Inc. (until Apr 11, 2022)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.